{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:30:50Z","timestamp":1790767850696,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.lpm.2016.11.010","type":"journal-article","created":{"date-parts":[[2016,12,28]],"date-time":"2016-12-28T15:15:56Z","timestamp":1482938156000},"page":"182-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"P1","title":["Neuropathologie et physiopathologie de la maladie de Parkinson\u00a0: focus sur l\u2019\u03b1-synucl\u00e9ine"],"prefix":"10.1016","volume":"46","author":[{"given":"Alice","family":"Prigent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Lionnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Ga\u00eblle","family":"Corbill\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Derkinderen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2016.11.010_bib0180","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","article-title":"Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria","volume":"8","author":"Dickson","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lpm.2016.11.010_bib0185","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.0509567103","article-title":"Lewy bodies","volume":"103","author":"Shults","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.lpm.2016.11.010_bib0190","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129\u00a0is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease","volume":"281","author":"Anderson","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lpm.2016.11.010_bib0195","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","article-title":"Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal","volume":"8","author":"Maroteaux","year":"1988","journal-title":"J Neurosci"},{"key":"10.1016\/j.lpm.2016.11.010_bib0200","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.lpm.2016.11.010_bib0205","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.lpm.2016.11.010_bib0210","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.lpm.2016.11.010_bib0215","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/jnnp.52.1.67","article-title":"Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease","volume":"52","author":"Lennox","year":"1989","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2016.11.010_bib0220","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF00687787","article-title":"Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study","volume":"75","author":"Kuzuhara","year":"1988","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.lpm.2016.11.010_bib0225","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s004010050918","article-title":"Accumulation of alpha-synuclein\/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy","volume":"96","author":"Wakabayashi","year":"1998","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.lpm.2016.11.010_bib0230","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archneur.58.2.186","article-title":"Synucleinopathies: clinical and pathological implications","volume":"58","author":"Galvin","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.lpm.2016.11.010_bib0235","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbadis.2008.09.013","article-title":"Molecular mechanisms of alpha-synuclein neurodegeneration","volume":"1792","author":"Waxman","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.lpm.2016.11.010_bib0240","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0304-3940(00)01153-8","article-title":"Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects","volume":"287","author":"Borghi","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.lpm.2016.11.010_bib0245","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1096\/fj.03-0098fje","article-title":"Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma","volume":"17","author":"El-Agnaf","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.lpm.2016.11.010_bib0250","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1523\/JNEUROSCI.0692-05.2005","article-title":"Intravesicular localization and exocytosis of alpha-synuclein and its aggregates","volume":"25","author":"Lee","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.lpm.2016.11.010_bib0255","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","article-title":"Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal","volume":"30","author":"Emmanouilidou","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.lpm.2016.11.010_bib0260","doi-asserted-by":"crossref","first-page":"e22225","DOI":"10.1371\/journal.pone.0022225","article-title":"Assessment of alpha-synuclein secretion in mouse and human brain parenchyma","volume":"6","author":"Emmanouilidou","year":"2011","journal-title":"PLoS One"},{"issue":"Suppl. 1","key":"10.1016\/j.lpm.2016.11.010_bib0265","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/jnc.13449","article-title":"Sorting out release, uptake and processing of alpha-synuclein during prion-like spread of pathology","author":"Tyson","year":"2016","journal-title":"J Neurochem"},{"key":"10.1016\/j.lpm.2016.11.010_bib0270","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S1474-4422(10)70213-1","article-title":"Are synucleinopathies prion-like disorders?","volume":"9","author":"Angot","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lpm.2016.11.010_bib0275","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm1746","article-title":"Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation","volume":"14","author":"Li","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.lpm.2016.11.010_bib0280","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease","volume":"14","author":"Kordower","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.lpm.2016.11.010_bib0285","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.lpm.2016.11.010_bib0290","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00401-010-0665-2","article-title":"Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease","volume":"119","author":"Del Tredici","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.lpm.2016.11.010_bib0295","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00401-008-0409-8","article-title":"Evaluation of alpha-synuclein immunohistochemical methods used by invited experts","volume":"116","author":"Beach","year":"2008","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.lpm.2016.11.010_bib0300","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","article-title":"Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders","volume":"119","author":"Beach","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.lpm.2016.11.010_bib0305","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00401-008-0450-7","article-title":"Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders","volume":"117","author":"Beach","year":"2009","journal-title":"Acta Neuropathol"},{"issue":"Suppl 3","key":"10.1016\/j.lpm.2016.11.010_bib0310","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1353-8020(09)70769-2","article-title":"Neuropathology of non-motor features of Parkinson disease","volume":"15","author":"Dickson","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.lpm.2016.11.010_bib0315","doi-asserted-by":"crossref","DOI":"10.1002\/mds.26605","article-title":"Neuropathological basis of nonmotor manifestations of Parkinson's disease","author":"Adler","year":"2016","journal-title":"Mov Disord"},{"key":"10.1016\/j.lpm.2016.11.010_bib0320","first-page":"325","article-title":"Neuronal loss in the substantia nigra in patients with Alzheimer's disease and Parkinson's disease in relation to extrapyramidal symptoms and dementia","volume":"317","author":"Rinne","year":"1989","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.lpm.2016.11.010_bib0325","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neurobiolaging.2008.03.015","article-title":"A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death","volume":"31","author":"Greffard","year":"2010","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.lpm.2016.11.010_bib0330","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00401-012-1040-2","article-title":"Parkinson's disease is not associated with gastrointestinal myenteric ganglion neuron loss","volume":"124","author":"Annerino","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.lpm.2016.11.010_bib0335","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3233\/JPD-140422","article-title":"Appraisal of the dopaminergic and noradrenergic innervation of the submucosal plexus in PD","volume":"4","author":"Corbill\u00e9","year":"2014","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.lpm.2016.11.010_bib0340","doi-asserted-by":"crossref","first-page":"e12728","DOI":"10.1371\/journal.pone.0012728","article-title":"Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms","volume":"5","author":"Lebouvier","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.lpm.2016.11.010_bib0345","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-3-211-45295-0_47","article-title":"Parkinson's disease: premotor clinico-pathological correlations","volume":"70","author":"Wolters","year":"2006","journal-title":"J Neural Transm"},{"key":"10.1016\/j.lpm.2016.11.010_bib0175","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1474-4422(15)00006-X","article-title":"Targeting \u03b1-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations","volume":"14","author":"Dehay","year":"2015","journal-title":"Lancet Neurol"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498216303633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498216303633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T09:27:31Z","timestamp":1601285251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498216303633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0755498216303633"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2016.11.010","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropathologie et physiopathologie de la maladie de Parkinson\u00a0: focus sur l\u2019\u03b1-synucl\u00e9ine","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2016.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}